Sight Sciences Inc (SGHT)

02:50 AM

Sight Sciences, Inc. (NASDAQ:SGHT) Short Interest Update - Defense World

02:50 AM

Mar 31, 2025

Charles Schwab Investment Management Inc. Raises Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

Mar 31, 2025

Mar 30, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Looks Inexpensive But Perhaps Not Attractive Enough - simplywall.st

Mar 30, 2025

Mar 29, 2025

Sight sciences chief legal officer sells shares worth $19,250 - MSN

Mar 29, 2025

Mar 26, 2025

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th - GlobeNewswire

Mar 26, 2025

Mar 25, 2025

Key Investor Updates Coming: Sight Sciences Takes Center Stage at Major Healthcare Conference - Stock Titan

Mar 25, 2025

Mar 25, 2025

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times

Mar 25, 2025

Mar 16, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of “Hold” from Analysts - Defense World

Mar 16, 2025

Mar 15, 2025

Sight sciences EVP Manohar Raheja buys $53,250 in stock By Investing.com - Investing.com Australia

Mar 15, 2025

Mar 13, 2025

Sight sciences EVP Manohar Raheja buys $53,250 in stock - Investing.com India

Mar 13, 2025

Mar 09, 2025

Piper Sandler Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $3.50 - Defense World

Mar 09, 2025

Mar 09, 2025

Sight Sciences’ (SGHT) Hold Rating Reiterated at Needham & Company LLC - Defense World

Mar 09, 2025

Mar 08, 2025

Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics - MSN

Mar 08, 2025

Mar 08, 2025

Lake Street Capital Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Mar 08, 2025

Mar 08, 2025

Stifel Nicolaus Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World

Mar 08, 2025

Mar 08, 2025

Earnings call transcript: Sight Sciences Q4 2024 results miss forecasts By Investing.com - Investing.com Australia

Mar 08, 2025

Mar 07, 2025

Actinic Keratosis Market Forecast 2034: EMA, PDMA, FDA Approvals, Prevalence, Clinical Trials, Treatment, Medication, Therapies, and Companies by DelveInsight - The Globe and Mail

Mar 07, 2025

Mar 07, 2025

Sight Sciences Inc. (SGHT) reports earnings - Quartz

Mar 07, 2025

Mar 07, 2025

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results, Initiates Full Year 2025 Financial Guidance - Vision Monday

Mar 07, 2025

Mar 06, 2025

Sight Sciences Faces Headwinds in Glaucoma and Dry Eye Markets, Hold Rating Maintained - TipRanks

Mar 06, 2025

Mar 06, 2025

Sight Sciences’ Earnings Call: Cautious Optimism Amid Challenges - TipRanks

Mar 06, 2025

Mar 06, 2025

Sight Sciences price target lowered to $3.50 from $5.50 at Piper Sandler - TipRanks

Mar 06, 2025

Mar 06, 2025

Stifel cuts Sight Sciences price target to $4, maintains Buy rating By Investing.com - Investing.com South Africa

Mar 06, 2025

Mar 06, 2025

Stifel cuts Sight Sciences price target to $4, maintains Buy rating - Investing.com

Mar 06, 2025

Mar 06, 2025

Sight Sciences Stock Hits 52-Week Low at $2.27 Amid Market Challenges - Investing.com India

Mar 06, 2025

Mar 06, 2025

Sight Sciences Stock Hits 52-Week Low at $2.27 Amid Market Challenges By Investing.com - Investing.com South Africa

Mar 06, 2025

Mar 06, 2025

Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 06, 2025

Mar 06, 2025

Citigroup Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $3.00 - Defense World

Mar 06, 2025

Mar 05, 2025

Sight Sciences Reports 2024 Results and 2025 Outlook - TipRanks

Mar 05, 2025

Mar 05, 2025

Earnings call transcript: Sight Sciences Q4 2024 results miss forecasts - Investing.com India

Mar 05, 2025

Mar 05, 2025

Sight Sciences Expects 2025 Revenue To Decline By 6% To 12% - Nasdaq

Mar 05, 2025

Mar 05, 2025

Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 05, 2025

Mar 05, 2025

Sight Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 05, 2025

Mar 05, 2025

Sight Sciences Reports 2024 Financial Results and 2025 Outlook - TipRanks

Mar 05, 2025

Mar 05, 2025

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance - The Manila Times

Mar 05, 2025

Mar 05, 2025

Sight Sciences earnings missed by $0.01, revenue fell short of estimates - Investing.com UK

Mar 05, 2025

Mar 05, 2025

Sight Sciences Reports Fourth Quarter and Full Year 2024 - GlobeNewswire

Mar 05, 2025

Mar 04, 2025

Breaking Down Sight Sciences: 6 Analysts Share Their Views - Benzinga

Mar 04, 2025

Mar 04, 2025

908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 04, 2025

Mar 03, 2025

Sight Sciences Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView

Mar 03, 2025

Mar 03, 2025

March 2025 Penny Stocks To Consider For Growth - Simply Wall St

Mar 03, 2025

Mar 03, 2025

Sight Sciences (SGHT) Projected to Post Earnings on Wednesday - Defense World

Mar 03, 2025

Mar 01, 2025

Sight Sciences (SGHT) to Release Quarterly Earnings on Wednesday - MarketBeat

Mar 01, 2025

Feb 26, 2025

Will Sight Sciences, Inc. (SGHT) Report Negative Earnings Next Week? What You Should Know - MSN

Feb 26, 2025

Feb 25, 2025

Institutional owners may consider drastic measures as Sight Sciences, Inc.'s (NASDAQ:SGHT) recent US$14m drop adds to long-term losses - Simply Wall St

Feb 25, 2025

Feb 25, 2025

Sight Sciences To Present Clinical Data On OMNI Surgical System At AGS Annual Meeting 2025 - Nasdaq

Feb 25, 2025

Feb 24, 2025

Sight Sciences stock hits 52-week low at $2.47 amid market challenges - Investing.com Nigeria

Feb 24, 2025

Feb 24, 2025

Sight Sciences to Present Comprehensive Clinical Data on - GlobeNewswire

Feb 24, 2025

Feb 24, 2025

Can This Groundbreaking Glaucoma Treatment Transform Patient Care? New Data Reveals 3-Year Outcomes - StockTitan

Feb 24, 2025